Diagnostic Imaging's Weekly Scan: August 30 — September 5

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

In a recent episode of our Molecular Imaging in Focus series, Sharmila Dorbala, MD, MPH, discussed phase 3 study findings on the use of the PET/CT radiotracer 124I- evuzamatide for overall detection of cardiac amyloidosis as well as the subtypes light-chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) cardiac amyloidosis.

New research suggests that photon-counting CT provides comparable sensitivity to breast MRI for lesion characterization, higher accuracy than MRI for nodal metastasis and lower detection of microcalcifications in comparison to full-field digital mammography.

The use of adjunctive AI for pulmonary nodule assessment on chest CT exams led to over a three-minute reduction in median reporting time, according to newly reported research in the journal Radiology.

In the first of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed recently published research showing significant declines in computed tomography (CT) radiation dosing over the past decade.

In comparison to contrast-enhanced CT, FAPI PET was associated with over 27 percent higher sensitivity for peritoneal carcinomatosis in the small bowel and 53 percent higher sensitivity in the upper abdomen, according to a new study involving 200 women with primary ovarian carcinoma.